How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191 [Yahoo! Finance]
Zymeworks Inc. (ZYME)
Last zymeworks inc. earnings: 3/2 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.zymeworks.com/overview
Company Research
Source: Yahoo! Finance
patients with advanced or metastatic platinum-resistant ovarian cancer, which is currently being evaluated in an ongoing Phase 1 trial of advanced solid tumors. This regulatory milestone, together with upcoming presentations of early clinical and extensive preclinical data on ZW191 and a new pan-RAS inhibitor ADC platform at the April 2026 AACR meeting, highlights how Zymeworks is working to expand its wholly owned oncology pipeline across multiple hard-to-treat, biomarker-defined cancers. We'll now examine how FDA Fast Track status for ZW191 could influence Zymeworks' royalty-focused investment narrative and perception of its pipeline. Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. Zymeworks Investment Narrative Recap To own Zymeworks today, you need to believe that its partnered royalty stream from zanidatamab can eve
Show less
Read more
Impact Snapshot
Event Time:
ZYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYME alerts
High impacting Zymeworks Inc. news events
Weekly update
A roundup of the hottest topics
ZYME
News
- Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
- Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of GrowthGlobeNewswire
- Zymeworks appoints Kristin Stafford as CFO [Seeking Alpha]Seeking Alpha
- Zymeworks Appoints Kristin Stafford as Chief Financial OfficerGlobeNewswire
- Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRa-Targeting Antibody-Drug Conjugate [Yahoo! Finance]Yahoo! Finance
ZYME
Earnings
- 3/2/26 - Miss
ZYME
Sec Filings
- 4/10/26 - Form 4
- 4/10/26 - Form 4
- 4/10/26 - Form 3
- ZYME's page on the SEC website